SPROSpero Therapeutics, Inc.
1.220USD-0.81%Mkt Cap: 71.05M $P/E: 8.713d ago
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap71.05M $
Enterprise Value21.73M $
Revenue (TTM)47.00M $
Gross Profit26.46M $
Net Income (TTM)8.57M $
Revenue/Share0.8250 USD
Last Price1.220 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees25
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS84833T1034
Valuation
P/E (Trailing)8.71
P/E (Forward)-1.09
PEG—
EV/EBITDA—
EV/Revenue0.46
P/S1.50
P/B1.59
EPS (TTM)0.14
EPS (Forward)-1.11
52W Range
1.0807% of range3.080
52W High3.080 USD
52W Low1.080 USD
Profitability
Gross Margin56.31%
Oper. Margin14.07%
EBITDA Margin0.00%
Profit Margin14.38%
ROE14.52%
ROA12.44%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.62M $
CapEx (TTM)—
FCF Margin61.38%
FCF Yield40.61%
Net Debt-48.73M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio6.12
Quick Ratio6.03
Book Value/Sh0.7600 USD
Cash/Share0.8720 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.000 USD
Upside (mean)+227.9%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.58.23M
Float46.72M
Insiders22.61%
Institutions18.23%
Short Interest
Short Ratio0.7d
Short % Float3.15%
Short % Out.2.61%
Shares Short1.51M
Short (prev mo.)2.86M
Technical
SMA 501.735 (-29.7%)
SMA 2002.285 (-46.6%)
Beta1.48
S&P 52W Chg18.16%
Avg Vol (30d)1.76M
Avg Vol (10d)580.04K
Technical Indicators
RSI (14)34.6
MACD-0.1449
MACD Signal-0.1869
MACD Hist.+0.0420
BB Upper1.279 USD
BB Middle1.211 USD
BB Lower1.143 USD
BB Width11.27%
ATR (14)0.0893 USD
Vol Ratio (20d)0.23x